Table 1.
Modification 1 | Direction 2 | Sequence (5′→3′) 3 |
---|---|---|
UL13-K157A | Forward | AGCTATGGAGAAGTTAAAGTATTTAAGGGTGCAAATGTAGCCGTCGCGAAGGTGTTCGAGTGTTTTAGGGATAACAGGGTAATCGATTT |
Reverse | CAGTGTCATAAGCAATTCGGTCTTGAAACACTCGAACACCTTCGCGACGGCTACATTTGCACCCTGCCAGTGTTACAACCAATTAACC | |
UL13-A157K | Forward | AGCTATGGAGAAGTTAAAGTATTTAAGGGTGCAAATGTAGCCGTCAAAAAGGTGTTCGAGTGTTTTAGGGATAACAGGGTAATCGATTT |
Reverse | CAGTGTCATAAGCAATTCGGTCTTGAAACACTCGAACACCTTTTTGACGGCTACATTTGCACCCTGCCAGTGTTACAACCAATTAACC |
1 Modification of the 301B/1 genome using two-step Red recombination. 2 Directionality of the primer. 3 Italics indicate the template-binding region of the primers for PCR amplification with pEP-KanSII. Red indicates unique upstream integration sequences. Green indicates unique downstream integration sequences. Nucleotides targeted (position 157 of UL13) for mutagenesis are underlined.